Effects and Mechanisms of Apolipoprotein A-V on the Regulation of Lipid Accumulation in Cardiomyocytes

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2018 Mar 14

PMID 29530023

Citations 2

Authors

Jun Luo

Li Xu

Jiang Li

Shuiping Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Apolipoprotein (apo) A-V is a key regulator of triglyceride (TG) metabolism. We investigated effects of apoA-V on lipid metabolism in cardiomyocytes in this study.

Methods: We first examined whether apoA-V can be taken up by cardiomyocytes and whether low density lipoprotein receptor family members participate in this process. Next, triglyceride (TG) content and lipid droplet changes were detected at different concentrations of apoA-V in normal and lipid-accumulation cells in normal and obese animals. Finally, we tested the levels of fatty acids (FAs) taken up into cardiomyocytes and lipid secretion through [C]-oleic acid.

Results: Our results show that heart tissue has apoA-V protein, and apoA-V is taken up by cardiomyocytes. When HL-1 cells were transfected with low density lipoprotein receptor (LDLR)-related protein 1(LRP1) siRNA, apoA-V intake decreased by 53% (P<0.05), while a 37% lipid accumulation in HL-1 cells remain unchanged. ApoA-V localized to the cytoplasm and was associated with lipid droplets in HL-1 cells. A 1200 and 1800 ng/mL apoA-V intervention decreased TG content by 28% and 45% in HL-1 cells, respectively and decreased TG content by 39% in mouse heart tissue (P<0.05). However, apoA-V had no effects on TG content in either normal HL-1 cells or mice. The levels of FAs taken up into cardiomyocytes decreased by 43% (P < 0.05), and the levels of TG and cholesterol ester secretion increased by 1.2-fold and 1.6-fold, respectively (P < 0.05).

Conclusion: ApoA-V is a novel regulator of lipid metabolism in cardiomyocytes.

Citing Articles

Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism.

Chen J, Luo J, Qiu H, Tang Y, Yang X, Chen Y Lipids Health Dis. 2022; 21(1):69.

PMID: 35941581 PMC: 9358849. DOI: 10.1186/s12944-022-01680-4.

Dissecting the Gene Expression Networks Associated with Variations in the Major Components of the Fatty Acid Muscle Profile in Large White Heavy Pigs.

Zappaterra M, Gioiosa S, Chillemi G, Zambonelli P, Davoli R Animals (Basel). 2021; 11(3).

PMID: 33673460 PMC: 7997476. DOI: 10.3390/ani11030628.

References

Chan J, Malik V, Jia W, Kadowaki T, Yajnik C, Yoon K . Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009; 301(20):2129-40. DOI: 10.1001/jama.2009.726. View

Hubert H, Feinleib M, MCNAMARA P, CASTELLI W . Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5):968-77. DOI: 10.1161/01.cir.67.5.968. View

Luo F, Guo Y, Ruan G, Peng R, Li X . Estrogen lowers triglyceride via regulating hepatic APOA5 expression. Lipids Health Dis. 2017; 16(1):72. PMC: 5381129. DOI: 10.1186/s12944-017-0463-0. View

Cal R, Castellano J, Revuelta-Lopez E, Aledo R, Barriga M, Farre J . Low-density lipoprotein receptor-related protein 1 mediates hypoxia-induced very low density lipoprotein-cholesteryl ester uptake and accumulation in cardiomyocytes. Cardiovasc Res. 2012; 94(3):469-79. DOI: 10.1093/cvr/cvs136. View

Zheng X, Yu B, Xie Y, Zhao S, Wu C . Apolipoprotein A5 regulates intracellular triglyceride metabolism in adipocytes. Mol Med Rep. 2017; 16(5):6771-6779. PMC: 5865834. DOI: 10.3892/mmr.2017.7461. View

Lamberts R, van Rijen M, Sipkema P, Fransen P, Sys S, Westerhof N . Coronary perfusion and muscle lengthening increase cardiac contraction: different stretch-triggered mechanisms. Am J Physiol Heart Circ Physiol. 2002; 283(4):H1515-22. DOI: 10.1152/ajpheart.00113.2002. View

Castellano J, Aledo R, Sendra J, Costales P, Juan-Babot O, Badimon L . Hypoxia stimulates low-density lipoprotein receptor-related protein-1 expression through hypoxia-inducible factor-1α in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2011; 31(6):1411-20. DOI: 10.1161/ATVBAHA.111.225490. View

Wang H, Sztalryd C . Oxidative tissue: perilipin 5 links storage with the furnace. Trends Endocrinol Metab. 2011; 22(6):197-203. PMC: 3122074. DOI: 10.1016/j.tem.2011.03.008. View

Braun N, Mohler P, Weisgraber K, Hasty A, Linton M, Yancey P . Intracellular trafficking of recycling apolipoprotein E in Chinese hamster ovary cells. J Lipid Res. 2006; 47(6):1176-86. DOI: 10.1194/jlr.M500503-JLR200. View

10.

van der Vliet H, Sammels M, Leegwater A, Levels J, Reitsma P, Boers W . Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem. 2001; 276(48):44512-20. DOI: 10.1074/jbc.M106888200. View

11.

Claycomb W, Lanson Jr N, Stallworth B, Egeland D, Delcarpio J, Bahinski A . HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 1998; 95(6):2979-84. PMC: 19680. DOI: 10.1073/pnas.95.6.2979. View

12.

Wende A, Abel E . Lipotoxicity in the heart. Biochim Biophys Acta. 2009; 1801(3):311-9. PMC: 2823976. DOI: 10.1016/j.bbalip.2009.09.023. View

13.

Nielsen L, Bartels E, Bollano E . Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem. 2002; 277(30):27014-20. DOI: 10.1074/jbc.M203458200. View

14.

Aasum E, Hafstad A, Severson D, Larsen T . Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes. 2003; 52(2):434-41. DOI: 10.2337/diabetes.52.2.434. View

15.

Carley A, Kleinfeld A . Fatty acid (FFA) transport in cardiomyocytes revealed by imaging unbound FFA is mediated by an FFA pump modulated by the CD36 protein. J Biol Chem. 2010; 286(6):4589-97. PMC: 3039365. DOI: 10.1074/jbc.M110.182162. View

16.

Nilsson S, Lookene A, Beckstead J, Gliemann J, Ryan R, Olivecrona G . Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry. 2007; 46(12):3896-904. DOI: 10.1021/bi7000533. View

17.

Brasaemle D . Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res. 2007; 48(12):2547-59. DOI: 10.1194/jlr.R700014-JLR200. View

18.

Ng A, Delgado V, Bertini M, van der Meer R, Rijzewijk L, Ewe S . Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation. 2010; 122(24):2538-44. DOI: 10.1161/CIRCULATIONAHA.110.955542. View

19.

Ouwens D, Boer C, Fodor M, de Galan P, Heine R, Maassen J . Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats. Diabetologia. 2005; 48(6):1229-37. DOI: 10.1007/s00125-005-1755-x. View

20.

Wilson P, DAgostino R, Sullivan L, Parise H, Kannel W . Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002; 162(16):1867-72. DOI: 10.1001/archinte.162.16.1867. View